Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

Authors: Steven D. Nathan, Jürgen Behr, Harold R. Collard, Vincent Cottin, Marius M. Hoeper, Fernando J. Martínez, Tamera J. Corte, Anne Keogh, Hanno Leuchte, Nesrin Moğulkoç, Silvia Ulrich, Wim Wuyts, Zhen Yao, Francis Boateng, Athol U. Wells - The Lancet 2019 cited by 241